BackLevel Biotechnology Overview

Level Biotechnology Profit Margin

Valuation check: 3118.TWO's profit margin is 9.28%, below the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

8.26%
↓ 38.39% YoY

As of Sep 2026

Annual Profit Margin (TTM)

9.28%
↓ 13.42% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Level Biotechnology (3118.TWO) FAQ

Level Biotechnology (3118.TWO) currently reports a profit margin of 9.28% as of September 2026. That compares with 10.72% in the prior-year period — down 13.4% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore Level Biotechnology's profit margin history and peer comparisons.

Level Biotechnology's profit margin decreased from 10.72% to 9.28% — a 13.4% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Level Biotechnology's profit margin of 9.28% is lower than the Healthcare sector average of 17.63%. That is roughly 47.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Level Biotechnology's current 9.28% should be judged against Healthcare norms (sector average: 17.63%) and against 3118.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 9.28%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for Level Biotechnology, and consider following 3118.TWO for alerts when major investors trade the stock.